Literature DB >> 26906614

The BCG Strain Pool: Diversity Matters.

Daria Bottai1, Roland Brosch2.   

Abstract

Mesh：

Year:  2016        PMID： 26906614      PMCID： PMC4817828          DOI： 10.1038/mt.2016.18

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  23 in total

1.  Increased protective efficacy of recombinant BCG strains expressing virulence-neutral proteins of the ESX-1 secretion system.

Authors:  Daria Bottai; Wafa Frigui; Simon Clark; Emma Rayner; Andrea Zelmer; Nuria Andreu; Marien I de Jonge; Gregory J Bancroft; Ann Williams; Priscille Brodin; Roland Brosch
Journal:  Vaccine       Date:  2015-04-11       Impact factor: 3.641

Review 2.  Release of mycobacterial antigens.

Authors:  Laleh Majlessi; Rafael Prados-Rosales; Arturo Casadevall; Roland Brosch
Journal:  Immunol Rev       Date:  2015-03       Impact factor: 12.988

3.  Mycobacterium tuberculosis Meets the Cytosol: The Role of cGAS in Anti-mycobacterial Immunity.

Authors:  Laleh Majlessi; Roland Brosch
Journal:  Cell Host Microbe       Date:  2015-06-10       Impact factor: 21.023

4.  A comprehensive survey of single nucleotide polymorphisms (SNPs) across Mycobacterium bovis strains and M. bovis BCG vaccine strains refines the genealogy and defines a minimal set of SNPs that separate virulent M. bovis strains and M. bovis BCG strains.

Authors:  M Carmen Garcia Pelayo; Swapna Uplekar; Andrew Keniry; Pablo Mendoza Lopez; Thierry Garnier; Javier Nunez Garcia; Laura Boschiroli; Xiangmei Zhou; Julian Parkhill; Noel Smith; R Glyn Hewinson; Stewart T Cole; Stephen V Gordon
Journal:  Infect Immun       Date:  2009-03-16       Impact factor: 3.441

5.  Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial.

Authors:  François Spertini; Régine Audran; Reza Chakour; Olfa Karoui; Viviane Steiner-Monard; Anne-Christine Thierry; Carole E Mayor; Nils Rettby; Katia Jaton; Laure Vallotton; Catherine Lazor-Blanchet; Juana Doce; Eugenia Puentes; Dessislava Marinova; Nacho Aguilo; Carlos Martin
Journal:  Lancet Respir Med       Date:  2015-11-17       Impact factor: 30.700

Review 6.  Influence of BCG vaccine strain on the immune response and protection against tuberculosis.

Authors:  Nicole Ritz; Willem A Hanekom; Roy Robins-Browne; Warwick J Britton; Nigel Curtis
Journal:  FEMS Microbiol Rev       Date:  2008-07-09       Impact factor: 16.408

7.  Developing whole mycobacteria cell vaccines for tuberculosis: Workshop proceedings, Max Planck Institute for Infection Biology, Berlin, Germany, July 9, 2014.

Authors: 
Journal:  Vaccine       Date:  2015-04-14       Impact factor: 3.641

8.  Cytosolic access of Mycobacterium tuberculosis: critical impact of phagosomal acidification control and demonstration of occurrence in vivo.

Authors:  Roxane Simeone; Fadel Sayes; Okryul Song; Matthias I Gröschel; Priscille Brodin; Roland Brosch; Laleh Majlessi
Journal:  PLoS Pathog       Date:  2015-02-06       Impact factor: 6.823

9.  Genomic expression catalogue of a global collection of BCG vaccine strains show evidence for highly diverged metabolic and cell-wall adaptations.

Authors:  Abdallah M Abdallah; Grant A Hill-Cawthorne; Thomas D Otto; Francesc Coll; José Afonso Guerra-Assunção; Ge Gao; Raeece Naeem; Hifzur Ansari; Tareq B Malas; Sabir A Adroub; Theo Verboom; Roy Ummels; Huoming Zhang; Aswini Kumar Panigrahi; Ruth McNerney; Roland Brosch; Taane G Clark; Marcel A Behr; Wilbert Bitter; Arnab Pain
Journal:  Sci Rep       Date:  2015-10-21       Impact factor: 4.379

10.  Impact of Mycobacterium tuberculosis RD1-locus on human primary dendritic cell immune functions.

Authors:  Marilena P Etna; Elena Giacomini; Manuela Pardini; Martina Severa; Daria Bottai; Melania Cruciani; Fabiana Rizzo; Raffaele Calogero; Roland Brosch; Eliana M Coccia
Journal:  Sci Rep       Date:  2015-11-25       Impact factor: 4.379
View more
  4 in total

1.  Are there differences among bacillus Calmette-Guérin (BCG) strains regarding their clinical efficacy in the treatment of non-muscleinvasive bladder cancer? The jury is still out but the answer is likely no.

Authors:  Guan Hee Tan; Cynthia Kuk; Alexandre R Zlotta
Journal:  Can Urol Assoc J       Date:  2019-07-23       Impact factor: 1.862

Review 2.  What Have We Learnt about BCG Vaccination in the Last 20 Years?

Authors:  Hazel M Dockrell; Steven G Smith
Journal:  Front Immunol       Date:  2017-09-13       Impact factor: 7.561

3.  CD4+ T Cells Recognizing PE/PPE Antigens Directly or via Cross Reactivity Are Protective against Pulmonary Mycobacterium tuberculosis Infection.

Authors:  Fadel Sayes; Alexandre Pawlik; Wafa Frigui; Matthias I Gröschel; Samuel Crommelynck; Catherine Fayolle; Felipe Cia; Gregory J Bancroft; Daria Bottai; Claude Leclerc; Roland Brosch; Laleh Majlessi
Journal:  PLoS Pathog       Date:  2016-07-28       Impact factor: 6.823

4.  BCG skin reactions by 2 months of age are associated with better survival in infancy: a prospective observational study from Guinea-Bissau.

Authors:  Frederik Schaltz-Buchholzer; Mike Berendsen; Adam Roth; Kristoffer Jarlov Jensen; Morten Bjerregaard-Andersen; Marcus Kjær Sørensen; Ivan Monteiro; Peter Aaby; Christine Stabell Benn
Journal:  BMJ Glob Health       Date:  2020-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.